Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Antisense Oligonucleotide-Based Therapy of Viral Infections
Woan‐Yuh Tarn, Yun Cheng, Shih-Han Ko, et al.
Pharmaceutics (2021) Vol. 13, Iss. 12, pp. 2015-2015
Open Access | Times Cited: 41

Showing 1-25 of 41 citing articles:

Possibilities and limitations of antisense oligonucleotide therapies for the treatment of monogenic disorders
Marlen C. Lauffer, Willeke M. C. van Roon‐Mom, Annemieke Aartsma‐Rus
Communications Medicine (2024) Vol. 4, Iss. 1
Open Access | Times Cited: 61
Innovations in the Treatment of Dystrophic Epidermolysis Bullosa (DEB): Current Landscape and Prospects
Ping‐Chen Hou, Nathalie del Agua, Su M. Lwin, et al.
Therapeutics and Clinical Risk Management (2023) Vol. Volume 19, pp. 455-473
Open Access | Times Cited: 27
Targeting materials and strategies for RNA delivery
Lixin Lin, Kexin Su, Qiang Cheng, et al.
Theranostics (2023) Vol. 13, Iss. 13, pp. 4667-4693
Open Access | Times Cited: 24
Metal‐Organic Frameworks Nanocarriers for Functional Nucleic Acid Delivery in Biomedical Applications
He Li, Mengdi Shang, Zhongkai Chen, et al.
The Chemical Record (2023) Vol. 23, Iss. 6
Closed Access | Times Cited: 20
A review of RNA nanoparticles for drug/gene/protein delivery in advanced therapies: Current state and future prospects
Pegah Vosoughi, Seyed Morteza Naghib, Babak Mikaeeli Kangarshahi, et al.
International Journal of Biological Macromolecules (2025) Vol. 295, pp. 139532-139532
Closed Access
Internal Ribosome Entry Site (IRES)-Mediated Translation and Its Potential for Novel mRNA-Based Therapy Development
Rita Marques, Rafaela Lacerda, Luı́sa Romão
Biomedicines (2022) Vol. 10, Iss. 8, pp. 1865-1865
Open Access | Times Cited: 30
Structural and Functional RNA Motifs of SARS-CoV-2 and Influenza A Virus as a Target of Viral Inhibitors
Izabela Szczesniak, Agnieszka Baliga-Gil, Aleksandra Jarmolowicz, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 2, pp. 1232-1232
Open Access | Times Cited: 16
Novel antiviral approaches for Marburg: a promising therapeutics in the pipeline
Shriyansh Srivastava, Sachin Kumar, Sumel Ashique, et al.
Frontiers in Microbiology (2024) Vol. 15
Open Access | Times Cited: 4
An overview of the role of Niemann-pick C1 (NPC1) in viral infections and inhibition of viral infections through NPC1 inhibitor
Ahmad Irfan, Seyede Narges Fatemi, Mohammad Ghaheri, et al.
Cell Communication and Signaling (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 13
STAT6-targeting antisense oligonucleotides against solitary fibrous tumor
Yi Li, José L. Mondaza-Hernández, David S. Moura, et al.
Molecular Therapy — Nucleic Acids (2024) Vol. 35, Iss. 2, pp. 102154-102154
Open Access | Times Cited: 4
Translational Control of COVID-19 and Its Therapeutic Implication
Dejiu Zhang, Lei Zhu, Yin Wang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 18
Lipid nanovehicles overcome barriers to systemic RNA delivery: Lipid components, fabrication methods, and rational design
Jing Yan, Hao Zhang, Guangfeng Li, et al.
Acta Pharmaceutica Sinica B (2023) Vol. 14, Iss. 2, pp. 579-601
Open Access | Times Cited: 9
Intracellular Pathogens: Infection, Immunity, and Intervention
Anna Martens-Koop, Aneesh Thakur
Methods in molecular biology (2024), pp. 1-17
Closed Access | Times Cited: 2
RNA-Based Vaccines and Therapeutics Against Intracellular Pathogens
Naga Suresh Kola, Dhruv J. Patel, Aneesh Thakur
Methods in molecular biology (2024), pp. 321-370
Closed Access | Times Cited: 2
Long‐term and Continuous Plasmonic Oligonucleotide Monitoring Enabled by Regeneration Approach
Abtin Saateh, Saeid Ansaryan, Jiarui Gao, et al.
Angewandte Chemie International Edition (2024) Vol. 63, Iss. 48
Open Access | Times Cited: 2
Recent Advances and Prospects in RNA Drug Development
Hidenori Tani
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 22, pp. 12284-12284
Open Access | Times Cited: 2
Antisense oligonucleotides targeting ORF1b block replication of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
Sophie Dhorne‐Pollet, Christopher J. Fitzpatrick, Bruno R. da Costa, et al.
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 13
Modified ASO conjugates encapsulated with cytidinyl/cationic lipids exhibit more potent and longer-lasting anti-HCC effects
Yufei Pan, Jing Guan, Yujing Gao, et al.
Molecular Therapy — Nucleic Acids (2023) Vol. 32, pp. 807-821
Open Access | Times Cited: 7
Cell-permeable peptide nucleic acid antisense oligonucleotide platform targeting human betacoronaviruses
Soree Park, Seong Ho Kim, Mehrangiz Dezhbord, et al.
Frontiers in Microbiology (2023) Vol. 14
Open Access | Times Cited: 7
Reduction of Tumor Growth with RNA-Targeting Treatment of the NAB2–STAT6 Fusion Transcript in Solitary Fibrous Tumor Models
Yi Li, John T. Nguyen, Manasvini Ammanamanchi, et al.
Cancers (2023) Vol. 15, Iss. 12, pp. 3127-3127
Open Access | Times Cited: 5
Antisense Therapy for Infectious Diseases
Lwanda Abonga Buthelezi, Shandre Pillay, Noxolo Ntuli, et al.
Cells (2023) Vol. 12, Iss. 16, pp. 2119-2119
Open Access | Times Cited: 5
RNA therapeutics for infectious diseases
Le Minh Tu Phan, Thi Thuy Duong Pham, Van Thai Than
Progress in molecular biology and translational science (2024), pp. 109-132
Closed Access | Times Cited: 1
Therapeutic potential of miRNAs in parasitic infectious diseases
Sanjana Mehrotra, Manu Kupani, Rajeev Kumar Pandey
Elsevier eBooks (2024), pp. 265-291
Closed Access | Times Cited: 1
Biopolymer-based coating materials for antiviral and antifungal applications: Recent advances in formulations and characterization
Zarin Tasnim Juthi, Mahe Jabeen, Md. Reazul Islam, et al.
Chemical Engineering Journal (2024) Vol. 498, pp. 155000-155000
Closed Access | Times Cited: 1
Effects of combinations of gapmer antisense oligonucleotides on the target reduction
Mitsugu Yanagidaira, Kotaro Yoshioka, Tetsuya Nagata, et al.
Molecular Biology Reports (2023) Vol. 50, Iss. 4, pp. 3539-3546
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top